Reletrans 20 micrograms / hour Transdermal Patches

Licence status
Authorised: 05/02/2016
Active substances
Buprenorphine
Dosage Form
Transdermal patch
Licence number
PA0711/236/004
Licence holder
Rowex Ltd

Product documents

Licence information

ATC code
N02AE Oripavine derivatives, N02AE01 buprenorphine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
05/02/2016